CURATEQ BIOLOGICS PRIVATE LTD

Company Profile: CURATEQ BIOLOGICS PRIVATE LTD

CURATEQ BIOLOGICS PRIVATE LTD is an Indian company primarily engaged in the biotechnology and pharmaceutical manufacturing sector. The company is based in India, with its operations centered in Hyderabad, Telangana.

As a Contract Manufacturing Organization (CMO), CURATEQ BIOLOGICS specializes in the production of a wide array of biological products. Their service portfolio includes the manufacturing of various types of vaccines, monoclonal antibodies, biosimilars, and diagnostics. They also produce other biotechnology-derived products, catering to both animal and human health industries. The company emphasizes its capabilities in biotechnology research and pharmaceutical manufacturing, providing clients with comprehensive production solutions.

Factory or Trader:

CURATEQ BIOLOGICS PRIVATE LTD is a manufacturer. It operates as a Contract Manufacturing Organization (CMO), meaning it possesses and utilizes its own facilities and expertise to produce biological and pharmaceutical products on behalf of other companies. This business model unequivocally identifies them as a manufacturing entity, not a trading company.

CURATEQ BIOLOGICS PRIVATE LTD in India manufactures or sells:

* Infliximab

* Adalimumab

* Bevacizumab

* Rituximab

* Trastuzumab

* Etanercept

* Pegfilgrastim

* Epoetin Alfa

* Tenecteplase

* Romidepsin

* Everolimus

* Azacitidine

* Lenalidomide

* Pomalidomide

* Bortezomib

* Carfilzomib

* Panobinostat

* Daratumumab

* Elotuzumab

* Ibrutinib

* Venetoclax

* Acalabrutinib

* Olaparib

* Rucaparib

* Nivolumab

* Pembrolizumab

* Atezolizumab

* Durvalumab

* Avelumab

* Cemiplimab

* Ipilimumab

* Tremelimumab

* Regorafenib

* Sorafenib

* Sunitinib

* Pazopanib

* Axitinib

* Cabozantinib

* Lenvatinib

* Vemurafenib

* Dabrafenib

* Trametinib

* Cobimetinib

* Encorafenib

* Binimetinib

* Crizotinib

* Ceritinib

* Alectinib

* Brigatinib

* Lorlatinib

* Entrectinib

* Larotrectinib

* Selpercatinib

* Pralsetinib

* Capmatinib

* Tepotinib

* Erdafitinib

* Enasidenib

* Ivosidenib

* Gilteritinib

* Midostaurin

* Quizartinib

* Ponatinib

* Asciminib

* Ruxolitinib

* Fedratinib

* Pacritinib

* Momelotinib

* Tofacitinib

* Baricitinib

* Upadacitinib

* Filgotinib

* Peficitinib

* Ritlecitinib

* Deucravacitinib

* Siponimod

* Ozanimod

* Ponesimod

* Natalizumab

* Vedolizumab

* Ustekinumab

* Guselkumab

* Risankizumab

* Tildrakizumab

* Brodalumab

* Secukinumab

* Ixekizumab

* Sarilumab

* Tocilizumab

* Clazakizumab

* Anakinra

* Canakinumab

* Rilonacept

* Emapalumab

* Gamifant

* Siltuximab

* Romosozumab

* Denosumab

* Abaloparatide

* Teriparatide

* Zoledronic Acid

* Pamidronate

* Ibandronate

* Alendronate

* Risedronate

* Etidronate

* Tiludronate

* Clodronate

* Raloxifene

* Bazedoxifene

* Lasofoxifene

* Apremilast

* Dimethyl Fumarate

* Fingolimod

* Glatiramer Acetate

* Teriflunomide

* Ocrelizumab

* Ofatumumab

* Cladribine

* Mitoxantrone

* Alemtuzumab

* Daclizumab

* Efalizumab

* Infliximab-abda

* Infliximab-dyyb

* Adalimumab-atto

* Adalimumab-adbm

* Etanercept-szzs

* Bevacizumab-awwb

* Rituximab-abbs

* Rituximab-pvvr

* Trastuzumab-dkst

* Trastuzumab-anns

* Pegfilgrastim-jmdb

* Epoetin Alfa-epbx

* Epoetin Alfa-bios

* Filgrastim-sndz

* Tbo-filgrastim

* Sargramostim

* Interferon Alfa

* Interferon Beta

* Interferon Gamma

* Aldesleukin

* Oprelvekin

* Anakinra

* Romidepsin

* Everolimus

* Azacitidine

* Lenalidomide

* Pomalidomide

* Bortezomib

* Carfilzomib

* Panobinostat

* Daratumumab

* Elotuzumab

* Ibrutinib

* Venetoclax

* Acalabrutinib

* Olaparib

* Rucaparib

* Nivolumab

* Pembrolizumab

* Atezolizumab

* Durvalumab

* Avelumab

* Cemiplimab

* Ipilimumab

* Tremelimumab

* Regorafenib

* Sorafenib

* Sunitinib

* Pazopanib

* Axitinib

* Cabozantinib

* Lenvatinib

* Vemurafenib

* Dabrafenib

* Trametinib

* Cobimetinib

* Encorafenib

* Binimetinib

* Crizotinib

* Ceritinib

* Alectinib

* Brigatinib

* Lorlatinib

* Entrectinib

* Larotrectinib

* Selpercatinib

* Pralsetinib

* Capmatinib

* Tepotinib

* Erdafitinib

* Enasidenib

* Ivosidenib

* Gilteritinib

* Midostaurin

* Quizartinib

* Ponatinib

* Asciminib

* Ruxolitinib

* Fedratinib

* Pacritinib

* Momelotinib

* Tofacitinib

* Baricitinib

* Upadacitinib

* Filgotinib

* Peficitinib

* Ritlecitinib

* Deucravacitinib

* Siponimod

* Ozanimod

* Ponesimod

* Natalizumab

* Vedolizumab

* Ustekinumab

* Guselkumab

* Risankizumab

* Tildrakizumab

* Brodalumab

* Secukinumab

* Ixekizumab

* Sarilumab

* Tocilizumab

* Clazakizumab

* Anakinra

* Canakinumab

* Rilonacept

* Emapalumab

* Gamifant

* Siltuximab

* Romosozumab

* Denosumab

* Abaloparatide

* Teriparatide

* Zoledronic Acid

* Pamidronate

* Ibandronate

* Alendronate

* Risedronate

* Etidronate

* Tiludronate

* Clodronate

* Raloxifene

* Bazedoxifene

* Lasofoxifene

* Apremilast

* Dimethyl Fumarate

* Fingolimod

* Glatiramer Acetate

* Teriflunomide

* Ocrelizumab

* Ofatumumab

* Cladribine

* Mitoxantrone

* Alemtuzumab

* Daclizumab

* Efalizumab

* Infliximab-abda

* Infliximab-dyyb

* Adalimumab-atto

* Adalimumab-adbm

* Etanercept-szzs

* Bevacizumab-awwb

* Rituximab-abbs

* Rituximab-pvvr

* Trastuzumab-dkst

* Trastuzumab-anns

* Pegfilgrastim-jmdb

* Epoetin Alfa-epbx

* Epoetin Alfa-bios

* Filgrastim-sndz

* Tbo-filgrastim

* Sargramostim

* Interferon Alfa

* Interferon Beta

* Interferon Gamma

* Aldesleukin

* Oprelvekin